speb/financial-data huggingface dataset:
URJA.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 1264000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1264000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 1246000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Net Income: 3713000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 3713000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2467000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
URJA.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 3713000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 3713000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2467000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -1264000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1264000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 5053000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 3713000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Operating Income: 2287000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 146142000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 1446000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 9544000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
URJA.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 2467000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 124286000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1322000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
URJA.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
URJA.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 0.00
URJA.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
URJA.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 143855000.00
URJA.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
URJA.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
URJA.NS income_statement (annual, 2026-03-31) — +Operating Expense: 105749000.00
URJA.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 24315000.00
URJA.NS income_statement (annual, 2026-03-31) — +Total Revenue: 667007000.00
URJA.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 175774000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 72096000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 72096000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 165901000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 165901000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 177956000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 177956000.00
URJA.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 445100000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 494750000.00
URJA.NS income_statement (annual, 2026-03-31) — Basic EPS: 0.03
URJA.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 0.00
URJA.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 34857000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 533901000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 533901000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 7308000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 7308000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 236882000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 236882000.00
URJA.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 678000.00
URJA.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -231498000.00
URJA.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -72801000.00
URJA.NS cash_flow (annual, 2026-03-31) — Change In Payable: -380791000.00
URJA.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 403905000.00
URJA.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -280507000.00
URJA.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -27549000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Common Stock: 533901000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 533901000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 1766678000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1766678000.00
URJA.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 544864000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 147892000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Current Assets: 951497000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 951497000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Current Debt: 35228000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 35228000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 35228000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 35228000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 512137000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 512137000.00
URJA.NS cash_flow (annual, 2026-03-31) — Deferred Tax: -21000.00
URJA.NS cash_flow (annual, 2026-03-31) — Depreciation: 5085000.00
URJA.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 5085000.00
URJA.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 4919000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1140000.00
URJA.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 4919000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 1140000.00
URJA.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 445100000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 494750000.00
URJA.NS income_statement (annual, 2026-03-31) — Diluted EPS: 0.03
URJA.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.00
URJA.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 13353000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1979000.00
URJA.NS income_statement (annual, 2026-03-31) — EBIT: 25289000.00
URJA.NS income_statement (quarterly, 2026-03-31) — EBIT: 4750000.00
URJA.NS income_statement (annual, 2026-03-31) — EBITDA: 30374000.00
URJA.NS income_statement (quarterly, 2026-03-31) — EBITDA: 5890000.00
URJA.NS cash_flow (annual, 2026-03-31) — End Cash Position: 7308000.00
URJA.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 2731000.00
URJA.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -261226000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Goodwill: 437370000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 437370000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 437370000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 437370000.00
URJA.NS income_statement (annual, 2026-03-31) — Gross Profit: 122143000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 27882000.00
URJA.NS income_statement (annual, 2026-03-31) — Interest Expense: 5421000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 1186000.00
URJA.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 5421000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1186000.00
URJA.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -5421000.00
URJA.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 6620000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Inventory: 405066000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 405066000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 1859002000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1859002000.00
URJA.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: 230946000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 177956000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 177956000.00
URJA.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 9419000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 57096000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 57096000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 57096000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 57096000.00
URJA.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 9419000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 143680000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 143680000.00
URJA.NS income_statement (annual, 2026-03-31) — Minority Interests: -123000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 4806000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Net Debt: 85016000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 85016000.00
URJA.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 2413000.00
URJA.NS income_statement (annual, 2026-03-31) — Net Income: 13353000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Net Income: 1979000.00
URJA.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 13353000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1979000.00
URJA.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 13476000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 3564000.00
URJA.NS income_statement (annual, 2026-03-31) — Net Income Discontinuous Operations: 0.00
URJA.NS income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: 0.00
URJA.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 13353000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1979000.00
URJA.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 13353000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1979000.00
URJA.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 19868000.00
URJA.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 13476000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 3564000.00
URJA.NS income_statement (annual, 2026-03-31) — Net Interest Income: -5421000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -1186000.00
URJA.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 9419000.00
URJA.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 9419000.00
URJA.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -5421000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1186000.00
URJA.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -1102000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Net PPE: 606581000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 606581000.00
URJA.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: 224326000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 1329308000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1329308000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 110000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 110000.00
URJA.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 30374000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 5890000.00
URJA.NS income_statement (annual, 2026-03-31) — Normalized Income: 13353000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 1979000.00
URJA.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -261226000.00
URJA.NS income_statement (annual, 2026-03-31) — Operating Income: 16394000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Operating Income: 3567000.00
URJA.NS income_statement (annual, 2026-03-31) — Operating Revenue: 667007000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 175774000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 557206000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 557206000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 143648000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 143648000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 24148000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 24148000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 1232777000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 1232777000.00
URJA.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -1199000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 786000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 786000.00
URJA.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 8895000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 1184000.00
URJA.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 56896000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 10257000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 229574000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 229574000.00
URJA.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
URJA.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
URJA.NS balance_sheet (annual, 2026-03-31) — Payables: 72096000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Payables: 72096000.00
URJA.NS income_statement (annual, 2026-03-31) — Pretax Income: 19868000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 3564000.00
URJA.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 544864000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 147892000.00
URJA.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 5085000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1140000.00
URJA.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 224326000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Share Issued: 557206000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 557206000.00
URJA.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
URJA.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
URJA.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 1766678000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1766678000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 1329308000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1329308000.00
URJA.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
URJA.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
URJA.NS income_statement (annual, 2026-03-31) — Tax Provision: 6392000.00
URJA.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.32
URJA.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
URJA.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -6031000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Total Assets: 2480145000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 2480145000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 1823774000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1823774000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Total Debt: 92324000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 92324000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 1910358000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1910358000.00
URJA.NS income_statement (annual, 2026-03-31) — Total Expenses: 650613000.00
URJA.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 172207000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 569787000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 569787000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 1528648000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1528648000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 57650000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 57650000.00
URJA.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
URJA.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
URJA.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
URJA.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
URJA.NS balance_sheet (annual, 2026-03-31) — Tradeand Other Payables Non Current: 554000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 554000.00
URJA.NS balance_sheet (annual, 2026-03-31) — Working Capital: 439360000.00
URJA.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 439360000.00
UROY income_statement (annual, 2022-04-30) — +Operating Expense: 5493000.00
UROY income_statement (annual, 2022-04-30) — +Total Revenue: 0.00
UROY balance_sheet (annual, 2022-04-30) — Accumulated Depreciation: 0.00
UROY cash_flow (annual, 2022-04-30) — Asset Impairment Charge: 125000.00
UROY income_statement (annual, 2022-04-30) — Basic Average Shares: 88268372.00
UROY income_statement (annual, 2022-04-30) — Basic EPS: -0.05
UROY cash_flow (annual, 2022-04-30) — Beginning Cash Position: 7214000.00
UROY cash_flow (annual, 2022-04-30) — Capital Expenditure: -13753000.00
UROY balance_sheet (annual, 2022-04-30) — Capital Lease Obligations: 120000.00
UROY balance_sheet (annual, 2022-04-30) — Capital Stock: 152444000.00
UROY balance_sheet (annual, 2022-04-30) — Cash And Cash Equivalents: 4385000.00
UROY balance_sheet (annual, 2022-04-30) — Cash Cash Equivalents And Short Term Investments: 56172000.00
UROY cash_flow (annual, 2022-04-30) — Cash Dividends Paid: 0.00
UROY balance_sheet (annual, 2022-04-30) — Cash Financial: 4385000.00
UROY cash_flow (annual, 2022-04-30) — Cash Flow From Continuing Financing Activities: 85064000.00
UROY cash_flow (annual, 2022-04-30) — Cash Flow From Continuing Investing Activities: -19090000.00
UROY cash_flow (annual, 2022-04-30) — Cash Flow From Continuing Operating Activities: -68802000.00
UROY cash_flow (annual, 2022-04-30) — Change In Inventory: -62610000.00
UROY cash_flow (annual, 2022-04-30) — Change In Payables And Accrued Expense: -60000.00
UROY cash_flow (annual, 2022-04-30) — Change In Prepaid Assets: -1963000.00
UROY cash_flow (annual, 2022-04-30) — Change In Working Capital: -64633000.00
UROY cash_flow (annual, 2022-04-30) — Changes In Cash: -2828000.00
UROY balance_sheet (annual, 2022-04-30) — Common Stock: 152444000.00
UROY balance_sheet (annual, 2022-04-30) — Common Stock Equity: 164636000.00
UROY cash_flow (annual, 2022-04-30) — Common Stock Issuance: 57734000.00
UROY income_statement (annual, 2022-04-30) — Cost Of Revenue: 0.00
UROY balance_sheet (annual, 2022-04-30) — Current Assets: 134030000.00
UROY balance_sheet (annual, 2022-04-30) — Current Capital Lease Obligation: 17000.00
UROY balance_sheet (annual, 2022-04-30) — Current Debt And Capital Lease Obligation: 17000.00
UROY balance_sheet (annual, 2022-04-30) — Current Liabilities: 486000.00
UROY cash_flow (annual, 2022-04-30) — Depreciation: 2000.00
UROY cash_flow (annual, 2022-04-30) — Depreciation Amortization Depletion: 2000.00
UROY income_statement (annual, 2022-04-30) — Depreciation Amortization Depletion Income Statement: 2000.00
UROY cash_flow (annual, 2022-04-30) — Depreciation And Amortization: 2000.00
UROY income_statement (annual, 2022-04-30) — Depreciation And Amortization In Income Statement: 2000.00
UROY income_statement (annual, 2022-04-30) — Depreciation Income Statement: 2000.00
UROY income_statement (annual, 2022-04-30) — Diluted Average Shares: 88268372.00
UROY income_statement (annual, 2022-04-30) — Diluted EPS: -0.05
UROY income_statement (annual, 2022-04-30) — Diluted NI Availto Com Stockholders: -4257000.00
UROY income_statement (annual, 2022-04-30) — EBIT: -5727000.00
UROY income_statement (annual, 2022-04-30) — EBITDA: -5725000.00
UROY cash_flow (annual, 2022-04-30) — Effect Of Exchange Rate Changes: -1000.00
UROY cash_flow (annual, 2022-04-30) — End Cash Position: 4385000.00
UROY balance_sheet (annual, 2022-04-30) — Financial Assets: 143000.00
UROY cash_flow (annual, 2022-04-30) — Financing Cash Flow: 85064000.00
UROY cash_flow (annual, 2022-04-30) — Free Cash Flow: -82555000.00
UROY cash_flow (annual, 2022-04-30) — Gain Loss On Investment Securities: -126000.00
UROY income_statement (annual, 2022-04-30) — Gain On Sale Of Security: -146000.00
UROY balance_sheet (annual, 2022-04-30) — Gains Losses Not Affecting Retained Earnings: 24335000.00
UROY income_statement (annual, 2022-04-30) — General And Administrative Expense: 4918000.00
UROY balance_sheet (annual, 2022-04-30) — Gross PPE: 44000000.00
UROY income_statement (annual, 2022-04-30) — Gross Profit: 0.00
UROY income_statement (annual, 2022-04-30) — Insurance And Claims: 489000.00
UROY income_statement (annual, 2022-04-30) — Interest Expense: 722000.00
UROY income_statement (annual, 2022-04-30) — Interest Expense Non Operating: 722000.00
UROY income_statement (annual, 2022-04-30) — Interest Income: 37000.00
UROY income_statement (annual, 2022-04-30) — Interest Income Non Operating: 37000.00
UROY cash_flow (annual, 2022-04-30) — Interest Paid Cff: -582000.00
UROY cash_flow (annual, 2022-04-30) — Interest Received Cfi: 37000.00
UROY balance_sheet (annual, 2022-04-30) — Inventory: 75030000.00
UROY balance_sheet (annual, 2022-04-30) — Invested Capital: 177584000.00
UROY cash_flow (annual, 2022-04-30) — Investing Cash Flow: -19090000.00
UROY cash_flow (annual, 2022-04-30) — Issuance Of Capital Stock: 57734000.00
UROY cash_flow (annual, 2022-04-30) — Issuance Of Debt: 12415000.00
UROY balance_sheet (annual, 2022-04-30) — Long Term Capital Lease Obligation: 103000.00
UROY balance_sheet (annual, 2022-04-30) — Long Term Debt: 12948000.00
UROY balance_sheet (annual, 2022-04-30) — Long Term Debt And Capital Lease Obligation: 13051000.00
UROY cash_flow (annual, 2022-04-30) — Long Term Debt Issuance: 12415000.00
UROY cash_flow (annual, 2022-04-30) — Long Term Debt Payments: -3000.00
UROY cash_flow (annual, 2022-04-30) — Net Common Stock Issuance: 57734000.00
UROY balance_sheet (annual, 2022-04-30) — Net Debt: 8563000.00
UROY cash_flow (annual, 2022-04-30) — Net Foreign Currency Exchange Gain Loss: 326000.00
UROY income_statement (annual, 2022-04-30) — Net Income: -4257000.00
UROY income_statement (annual, 2022-04-30) — Net Income Common Stockholders: -4257000.00
UROY income_statement (annual, 2022-04-30) — Net Income Continuous Operations: -4257000.00
UROY income_statement (annual, 2022-04-30) — Net Income From Continuing And Discontinued Operation: -4257000.00
UROY income_statement (annual, 2022-04-30) — Net Income From Continuing Operation Net Minority Interest: -4257000.00
UROY cash_flow (annual, 2022-04-30) — Net Income From Continuing Operations: -6449000.00
UROY income_statement (annual, 2022-04-30) — Net Income Including Noncontrolling Interests: -4257000.00
UROY income_statement (annual, 2022-04-30) — Net Interest Income: -685000.00
UROY cash_flow (annual, 2022-04-30) — Net Investment Purchase And Sale: -5374000.00
UROY cash_flow (annual, 2022-04-30) — Net Issuance Payments Of Debt: 12412000.00
UROY cash_flow (annual, 2022-04-30) — Net Long Term Debt Issuance: 12412000.00
UROY income_statement (annual, 2022-04-30) — Net Non Operating Interest Income Expense: -685000.00
UROY balance_sheet (annual, 2022-04-30) — Net PPE: 44000000.00
UROY cash_flow (annual, 2022-04-30) — Net PPE Purchase And Sale: -13753000.00
UROY balance_sheet (annual, 2022-04-30) — Net Tangible Assets: 164636000.00
UROY income_statement (annual, 2022-04-30) — Normalized EBITDA: -5454000.00
UROY income_statement (annual, 2022-04-30) — Normalized Income: -4078112.27
UROY cash_flow (annual, 2022-04-30) — Operating Cash Flow: -68802000.00
UROY cash_flow (annual, 2022-04-30) — Operating Gains Losses: 200000.00
UROY income_statement (annual, 2022-04-30) — Operating Income: -5493000.00
UROY income_statement (annual, 2022-04-30) — Operating Revenue: 0.00
UROY balance_sheet (annual, 2022-04-30) — Ordinary Shares Number: 95546314.00
UROY balance_sheet (annual, 2022-04-30) — Other Equity Adjustments: 24335000.00
UROY income_statement (annual, 2022-04-30) — Other Gand A: 2515000.00
UROY income_statement (annual, 2022-04-30) — Other Income Expense: -271000.00
UROY balance_sheet (annual, 2022-04-30) — Other Inventories: 75030000.00
UROY cash_flow (annual, 2022-04-30) — Other Non Cash Items: 685000.00
UROY income_statement (annual, 2022-04-30) — Other Operating Expenses: 573000.00
UROY balance_sheet (annual, 2022-04-30) — Other Properties: 120000.00
UROY balance_sheet (annual, 2022-04-30) — Other Receivables: 2131000.00
UROY balance_sheet (annual, 2022-04-30) — Other Short Term Investments: 51787000.00
UROY balance_sheet (annual, 2022-04-30) — Payables And Accrued Expenses: 469000.00
UROY balance_sheet (annual, 2022-04-30) — Prepaid Assets: 2131000.00
UROY income_statement (annual, 2022-04-30) — Pretax Income: -6449000.00
UROY cash_flow (annual, 2022-04-30) — Proceeds From Stock Option Exercised: 15500000.00
UROY cash_flow (annual, 2022-04-30) — Purchase Of Investment: -9670000.00
UROY cash_flow (annual, 2022-04-30) — Purchase Of PPE: -13753000.00
UROY balance_sheet (annual, 2022-04-30) — Receivables: 2131000.00
UROY income_statement (annual, 2022-04-30) — Reconciled Cost Of Revenue: 0.00
UROY income_statement (annual, 2022-04-30) — Reconciled Depreciation: 2000.00
UROY cash_flow (annual, 2022-04-30) — Repayment Of Debt: -3000.00
UROY balance_sheet (annual, 2022-04-30) — Restricted Cash: 697000.00
UROY balance_sheet (annual, 2022-04-30) — Retained Earnings: -12143000.00
UROY income_statement (annual, 2022-04-30) — Salaries And Wages: 1914000.00
UROY cash_flow (annual, 2022-04-30) — Sale Of Investment: 4296000.00
UROY income_statement (annual, 2022-04-30) — Selling And Marketing Expense: 1382000.00
UROY income_statement (annual, 2022-04-30) — Selling General And Administration: 4918000.00
UROY balance_sheet (annual, 2022-04-30) — Share Issued: 95546314.00
UROY income_statement (annual, 2022-04-30) — Special Income Charges: -125000.00
UROY cash_flow (annual, 2022-04-30) — Stock Based Compensation: 1268000.00
UROY balance_sheet (annual, 2022-04-30) — Stockholders Equity: 164636000.00
UROY balance_sheet (annual, 2022-04-30) — Tangible Book Value: 164636000.00
UROY income_statement (annual, 2022-04-30) — Tax Effect Of Unusual Items: -92112.27
UROY income_statement (annual, 2022-04-30) — Tax Provision: -2192000.00
UROY income_statement (annual, 2022-04-30) — Tax Rate For Calcs: 0.34
UROY balance_sheet (annual, 2022-04-30) — Total Assets: 178173000.00
UROY balance_sheet (annual, 2022-04-30) — Total Capitalization: 177584000.00
UROY balance_sheet (annual, 2022-04-30) — Total Debt: 13068000.00
UROY balance_sheet (annual, 2022-04-30) — Total Equity Gross Minority Interest: 164636000.00
UROY income_statement (annual, 2022-04-30) — Total Expenses: 5493000.00
UROY balance_sheet (annual, 2022-04-30) — Total Liabilities Net Minority Interest: 13537000.00
UROY balance_sheet (annual, 2022-04-30) — Total Non Current Assets: 44143000.00
UROY balance_sheet (annual, 2022-04-30) — Total Non Current Liabilities Net Minority Interest: 13051000.00
UROY income_statement (annual, 2022-04-30) — Total Operating Income As Reported: -5618000.00
UROY income_statement (annual, 2022-04-30) — Total Unusual Items: -271000.00
UROY income_statement (annual, 2022-04-30) — Total Unusual Items Excluding Goodwill: -271000.00
UROY balance_sheet (annual, 2022-04-30) — Working Capital: 133544000.00
UROY income_statement (annual, 2022-04-30) — Write Off: 125000.00
UROY income_statement (annual, 2023-04-30) — +Operating Expense: 6601000.00
UROY income_statement (annual, 2023-04-30) — +Total Revenue: 13854000.00
UROY balance_sheet (annual, 2023-04-30) — Accounts Payable: 549000.00
UROY balance_sheet (annual, 2023-04-30) — Accounts Receivable: 0.00
UROY balance_sheet (annual, 2023-04-30) — Accumulated Depreciation: -147000.00
UROY cash_flow (annual, 2023-04-30) — Asset Impairment Charge: 0.00
UROY income_statement (annual, 2023-04-30) — Basic Average Shares: 97948882.00
UROY income_statement (annual, 2023-04-30) — Basic EPS: -0.06
UROY cash_flow (annual, 2023-04-30) — Beginning Cash Position: 4385000.00
UROY cash_flow (annual, 2023-04-30) — Capital Expenditure: -2170000.00
UROY balance_sheet (annual, 2023-04-30) — Capital Lease Obligations: 104000.00
UROY balance_sheet (annual, 2023-04-30) — Capital Stock: 167277000.00
UROY balance_sheet (annual, 2023-04-30) — Cash And Cash Equivalents: 14306000.00
UROY balance_sheet (annual, 2023-04-30) — Cash Cash Equivalents And Short Term Investments: 52646000.00
UROY cash_flow (annual, 2023-04-30) — Cash Dividends Paid: 0.00
UROY balance_sheet (annual, 2023-04-30) — Cash Financial: 14306000.00
UROY cash_flow (annual, 2023-04-30) — Cash Flow From Continuing Financing Activities: 9196000.00
UROY cash_flow (annual, 2023-04-30) — Cash Flow From Continuing Investing Activities: 12186000.00
UROY cash_flow (annual, 2023-04-30) — Cash Flow From Continuing Operating Activities: -11462000.00
UROY cash_flow (annual, 2023-04-30) — Change In Account Payable: 80000.00
UROY cash_flow (annual, 2023-04-30) — Change In Inventory: -10384000.00
UROY cash_flow (annual, 2023-04-30) — Change In Payable: 80000.00
UROY cash_flow (annual, 2023-04-30) — Change In Payables And Accrued Expense: 80000.00
UROY cash_flow (annual, 2023-04-30) — Change In Prepaid Assets: 1620000.00
UROY cash_flow (annual, 2023-04-30) — Change In Receivables: 0.00
UROY cash_flow (annual, 2023-04-30) — Change In Working Capital: -8684000.00
UROY cash_flow (annual, 2023-04-30) — Changes In Account Receivables: 0.00
UROY cash_flow (annual, 2023-04-30) — Changes In Cash: 9920000.00
UROY balance_sheet (annual, 2023-04-30) — Common Stock: 167277000.00
UROY balance_sheet (annual, 2023-04-30) — Common Stock Equity: 175369000.00
UROY cash_flow (annual, 2023-04-30) — Common Stock Issuance: 14224000.00
UROY income_statement (annual, 2023-04-30) — Cost Of Revenue: 11035000.00
UROY balance_sheet (annual, 2023-04-30) — Current Assets: 138828000.00
UROY balance_sheet (annual, 2023-04-30) — Current Capital Lease Obligation: 21000.00
UROY balance_sheet (annual, 2023-04-30) — Current Debt: 9766000.00
UROY balance_sheet (annual, 2023-04-30) — Current Debt And Capital Lease Obligation: 9787000.00
UROY balance_sheet (annual, 2023-04-30) — Current Liabilities: 10336000.00
UROY cash_flow (annual, 2023-04-30) — Depreciation: 24000.00
UROY cash_flow (annual, 2023-04-30) — Depreciation Amortization Depletion: 24000.00
UROY income_statement (annual, 2023-04-30) — Depreciation Amortization Depletion Income Statement: 24000.00
UROY cash_flow (annual, 2023-04-30) — Depreciation And Amortization: 24000.00
UROY income_statement (annual, 2023-04-30) — Depreciation And Amortization In Income Statement: 24000.00
UROY income_statement (annual, 2023-04-30) — Depreciation Income Statement: 24000.00
UROY income_statement (annual, 2023-04-30) — Diluted Average Shares: 97948882.00
UROY income_statement (annual, 2023-04-30) — Diluted EPS: -0.06
UROY income_statement (annual, 2023-04-30) — Diluted NI Availto Com Stockholders: -5843000.00
UROY income_statement (annual, 2023-04-30) — EBIT: -4222000.00
UROY income_statement (annual, 2023-04-30) — EBITDA: -4198000.00
UROY cash_flow (annual, 2023-04-30) — Effect Of Exchange Rate Changes: 1000.00
UROY cash_flow (annual, 2023-04-30) — End Cash Position: 14306000.00
UROY balance_sheet (annual, 2023-04-30) — Financial Assets: 0.00
UROY cash_flow (annual, 2023-04-30) — Financing Cash Flow: 9196000.00
UROY cash_flow (annual, 2023-04-30) — Free Cash Flow: -13632000.00
UROY income_statement (annual, 2023-04-30) — Gain On Sale Of Security: -653000.00
UROY balance_sheet (annual, 2023-04-30) — Gains Losses Not Affecting Retained Earnings: 19947000.00
UROY income_statement (annual, 2023-04-30) — General And Administrative Expense: 6109000.00
UROY balance_sheet (annual, 2023-04-30) — Gross PPE: 47107000.00
UROY income_statement (annual, 2023-04-30) — Gross Profit: 2819000.00
UROY income_statement (annual, 2023-04-30) — Insurance And Claims: 511000.00
UROY income_statement (annual, 2023-04-30) — Interest Expense: 1636000.00
UROY income_statement (annual, 2023-04-30) — Interest Expense Non Operating: 1636000.00
UROY income_statement (annual, 2023-04-30) — Interest Income: 67000.00
UROY income_statement (annual, 2023-04-30) — Interest Income Non Operating: 67000.00
UROY cash_flow (annual, 2023-04-30) — Interest Paid Cff: -1348000.00
UROY cash_flow (annual, 2023-04-30) — Interest Received Cfi: 68000.00
UROY balance_sheet (annual, 2023-04-30) — Inventory: 85561000.00
UROY balance_sheet (annual, 2023-04-30) — Invested Capital: 185135000.00
UROY cash_flow (annual, 2023-04-30) — Investing Cash Flow: 12186000.00
UROY cash_flow (annual, 2023-04-30) — Issuance Of Capital Stock: 14224000.00
UROY balance_sheet (annual, 2023-04-30) — Long Term Capital Lease Obligation: 83000.00
UROY balance_sheet (annual, 2023-04-30) — Long Term Debt And Capital Lease Obligation: 83000.00
UROY cash_flow (annual, 2023-04-30) — Long Term Debt Payments: -25000.00
UROY cash_flow (annual, 2023-04-30) — Net Common Stock Issuance: 14224000.00
UROY cash_flow (annual, 2023-04-30) — Net Foreign Currency Exchange Gain Loss: 706000.00
UROY income_statement (annual, 2023-04-30) — Net Income: -5843000.00
UROY income_statement (annual, 2023-04-30) — Net Income Common Stockholders: -5843000.00
UROY income_statement (annual, 2023-04-30) — Net Income Continuous Operations: -5843000.00
UROY income_statement (annual, 2023-04-30) — Net Income From Continuing And Discontinued Operation: -5843000.00
UROY income_statement (annual, 2023-04-30) — Net Income From Continuing Operation Net Minority Interest: -5843000.00
UROY cash_flow (annual, 2023-04-30) — Net Income From Continuing Operations: -5858000.00
UROY income_statement (annual, 2023-04-30) — Net Income Including Noncontrolling Interests: -5843000.00
UROY income_statement (annual, 2023-04-30) — Net Interest Income: -1569000.00
UROY cash_flow (annual, 2023-04-30) — Net Investment Purchase And Sale: 13701000.00
UROY cash_flow (annual, 2023-04-30) — Net Issuance Payments Of Debt: -4193000.00
UROY cash_flow (annual, 2023-04-30) — Net Long Term Debt Issuance: -25000.00
UROY income_statement (annual, 2023-04-30) — Net Non Operating Interest Income Expense: -1569000.00
UROY cash_flow (annual, 2023-04-30) — Net Other Investing Changes: 587000.00
UROY balance_sheet (annual, 2023-04-30) — Net PPE: 46960000.00
UROY cash_flow (annual, 2023-04-30) — Net PPE Purchase And Sale: -2170000.00
UROY cash_flow (annual, 2023-04-30) — Net Short Term Debt Issuance: -4168000.00
UROY balance_sheet (annual, 2023-04-30) — Net Tangible Assets: 175369000.00
UROY income_statement (annual, 2023-04-30) — Normalized EBITDA: -3545000.00
UROY income_statement (annual, 2023-04-30) — Normalized Income: -5191672.07
UROY cash_flow (annual, 2023-04-30) — Operating Cash Flow: -11462000.00
UROY cash_flow (annual, 2023-04-30) — Operating Gains Losses: 706000.00
UROY income_statement (annual, 2023-04-30) — Operating Income: -3782000.00
UROY income_statement (annual, 2023-04-30) — Operating Revenue: 13854000.00
UROY balance_sheet (annual, 2023-04-30) — Ordinary Shares Number: 99803729.00
UROY balance_sheet (annual, 2023-04-30) — Other Current Borrowings: 9766000.00
UROY balance_sheet (annual, 2023-04-30) — Other Equity Adjustments: 19947000.00
UROY income_statement (annual, 2023-04-30) — Other Gand A: 4209000.00
UROY income_statement (annual, 2023-04-30) — Other Income Expense: -507000.00
UROY balance_sheet (annual, 2023-04-30) — Other Inventories: 85561000.00
UROY cash_flow (annual, 2023-04-30) — Other Non Cash Items: 1423000.00
UROY income_statement (annual, 2023-04-30) — Other Non Operating Income Expenses: 146000.00
UROY income_statement (annual, 2023-04-30) — Other Operating Expenses: 492000.00
UROY balance_sheet (annual, 2023-04-30) — Other Properties: 96000.00
UROY balance_sheet (annual, 2023-04-30) — Other Receivables: 511000.00
UROY balance_sheet (annual, 2023-04-30) — Other Short Term Investments: 38340000.00
UROY balance_sheet (annual, 2023-04-30) — Payables: 549000.00
UROY balance_sheet (annual, 2023-04-30) — Payables And Accrued Expenses: 549000.00
UROY balance_sheet (annual, 2023-04-30) — Prepaid Assets: 511000.00
UROY income_statement (annual, 2023-04-30) — Pretax Income: -5858000.00
UROY cash_flow (annual, 2023-04-30) — Proceeds From Stock Option Exercised: 513000.00
UROY cash_flow (annual, 2023-04-30) — Purchase Of Investment: -2850000.00
UROY cash_flow (annual, 2023-04-30) — Purchase Of PPE: -2170000.00
UROY balance_sheet (annual, 2023-04-30) — Receivables: 511000.00
UROY income_statement (annual, 2023-04-30) — Reconciled Cost Of Revenue: 11035000.00
UROY income_statement (annual, 2023-04-30) — Reconciled Depreciation: 24000.00
UROY cash_flow (annual, 2023-04-30) — Repayment Of Debt: -4193000.00
UROY balance_sheet (annual, 2023-04-30) — Restricted Cash: 110000.00
UROY balance_sheet (annual, 2023-04-30) — Retained Earnings: -11855000.00
UROY income_statement (annual, 2023-04-30) — Salaries And Wages: 1900000.00
UROY cash_flow (annual, 2023-04-30) — Sale Of Investment: 16551000.00
UROY income_statement (annual, 2023-04-30) — Selling General And Administration: 6109000.00
UROY balance_sheet (annual, 2023-04-30) — Share Issued: 99803729.00
UROY cash_flow (annual, 2023-04-30) — Short Term Debt Payments: -4168000.00
UROY income_statement (annual, 2023-04-30) — Special Income Charges: 0.00
UROY cash_flow (annual, 2023-04-30) — Stock Based Compensation: 927000.00
UROY balance_sheet (annual, 2023-04-30) — Stockholders Equity: 175369000.00
UROY balance_sheet (annual, 2023-04-30) — Tangible Book Value: 175369000.00
UROY income_statement (annual, 2023-04-30) — Tax Effect Of Unusual Items: -1672.07
UROY income_statement (annual, 2023-04-30) — Tax Provision: -15000.00
UROY income_statement (annual, 2023-04-30) — Tax Rate For Calcs: 0.00
UROY balance_sheet (annual, 2023-04-30) — Total Assets: 185788000.00
UROY balance_sheet (annual, 2023-04-30) — Total Capitalization: 175369000.00
UROY balance_sheet (annual, 2023-04-30) — Total Debt: 9870000.00
UROY balance_sheet (annual, 2023-04-30) — Total Equity Gross Minority Interest: 175369000.00
UROY income_statement (annual, 2023-04-30) — Total Expenses: 17636000.00
UROY balance_sheet (annual, 2023-04-30) — Total Liabilities Net Minority Interest: 10419000.00
UROY balance_sheet (annual, 2023-04-30) — Total Non Current Assets: 46960000.00
UROY balance_sheet (annual, 2023-04-30) — Total Non Current Liabilities Net Minority Interest: 83000.00
UROY income_statement (annual, 2023-04-30) — Total Operating Income As Reported: -3782000.00
UROY income_statement (annual, 2023-04-30) — Total Unusual Items: -653000.00
UROY income_statement (annual, 2023-04-30) — Total Unusual Items Excluding Goodwill: -653000.00
UROY balance_sheet (annual, 2023-04-30) — Working Capital: 128492000.00
UROY income_statement (annual, 2023-04-30) — Write Off: 0.00
UROY income_statement (annual, 2024-04-30) — +Operating Expense: 7678000.00
UROY income_statement (annual, 2024-04-30) — +Total Revenue: 42706000.00
UROY balance_sheet (annual, 2024-04-30) — Accounts Payable: 1202000.00
UROY balance_sheet (annual, 2024-04-30) — Accounts Receivable: 13818000.00
UROY balance_sheet (annual, 2024-04-30) — Accumulated Depreciation: -606000.00
UROY income_statement (annual, 2024-04-30) — Basic Average Shares: 108639674.00
UROY income_statement (annual, 2024-04-30) — Basic EPS: 0.09
UROY cash_flow (annual, 2024-04-30) — Beginning Cash Position: 14306000.00
UROY cash_flow (annual, 2024-04-30) — Capital Expenditure: -75000.00
UROY balance_sheet (annual, 2024-04-30) — Capital Lease Obligations: 193000.00
UROY balance_sheet (annual, 2024-04-30) — Capital Stock: 244397000.00
UROY balance_sheet (annual, 2024-04-30) — Cash And Cash Equivalents: 21100000.00
UROY balance_sheet (annual, 2024-04-30) — Cash Cash Equivalents And Short Term Investments: 30243000.00
UROY cash_flow (annual, 2024-04-30) — Cash Dividends Paid: 0.00
UROY balance_sheet (annual, 2024-04-30) — Cash Financial: 21100000.00
UROY cash_flow (annual, 2024-04-30) — Cash Flow From Continuing Financing Activities: 66603000.00
UROY cash_flow (annual, 2024-04-30) — Cash Flow From Continuing Investing Activities: 45235000.00
UROY cash_flow (annual, 2024-04-30) — Cash Flow From Continuing Operating Activities: -104843000.00
UROY cash_flow (annual, 2024-04-30) — Change In Account Payable: 653000.00
UROY cash_flow (annual, 2024-04-30) — Change In Inventory: -101069000.00
UROY cash_flow (annual, 2024-04-30) — Change In Payable: 2172000.00
UROY cash_flow (annual, 2024-04-30) — Change In Payables And Accrued Expense: 2172000.00
UROY cash_flow (annual, 2024-04-30) — Change In Prepaid Assets: 21000.00
UROY cash_flow (annual, 2024-04-30) — Change In Receivables: -13818000.00
UROY cash_flow (annual, 2024-04-30) — Change In Working Capital: -112694000.00
UROY cash_flow (annual, 2024-04-30) — Changes In Account Receivables: -13818000.00
UROY cash_flow (annual, 2024-04-30) — Changes In Cash: 6995000.00
UROY balance_sheet (annual, 2024-04-30) — Common Stock: 244397000.00
UROY balance_sheet (annual, 2024-04-30) — Common Stock Equity: 275789000.00
UROY cash_flow (annual, 2024-04-30) — Common Stock Issuance: 70479000.00
UROY income_statement (annual, 2024-04-30) — Cost Of Revenue: 27951000.00
UROY balance_sheet (annual, 2024-04-30) — Current Assets: 231751000.00
UROY balance_sheet (annual, 2024-04-30) — Current Capital Lease Obligation: 37000.00
UROY balance_sheet (annual, 2024-04-30) — Current Debt And Capital Lease Obligation: 37000.00
UROY balance_sheet (annual, 2024-04-30) — Current Liabilities: 2758000.00
UROY cash_flow (annual, 2024-04-30) — Depletion: 0.00
UROY cash_flow (annual, 2024-04-30) — Depreciation: 23000.00
UROY cash_flow (annual, 2024-04-30) — Depreciation Amortization Depletion: 23000.00
UROY cash_flow (annual, 2024-04-30) — Depreciation And Amortization: 23000.00
UROY income_statement (annual, 2024-04-30) — Diluted Average Shares: 115331146.00
UROY income_statement (annual, 2024-04-30) — Diluted EPS: 0.08
UROY income_statement (annual, 2024-04-30) — Diluted NI Availto Com Stockholders: 9780000.00
UROY income_statement (annual, 2024-04-30) — EBIT: 7766000.00
UROY income_statement (annual, 2024-04-30) — EBITDA: 7789000.00
UROY cash_flow (annual, 2024-04-30) — Effect Of Exchange Rate Changes: -201000.00
UROY cash_flow (annual, 2024-04-30) — End Cash Position: 21100000.00
UROY balance_sheet (annual, 2024-04-30) — Financial Assets: 0.00
UROY cash_flow (annual, 2024-04-30) — Financing Cash Flow: 66603000.00
UROY cash_flow (annual, 2024-04-30) — Free Cash Flow: -104918000.00
UROY income_statement (annual, 2024-04-30) — Gain On Sale Of Security: -201000.00
UROY balance_sheet (annual, 2024-04-30) — Gains Losses Not Affecting Retained Earnings: 8870000.00
UROY income_statement (annual, 2024-04-30) — General And Administrative Expense: 6921000.00
UROY balance_sheet (annual, 2024-04-30) — Gross PPE: 47558000.00
UROY income_statement (annual, 2024-04-30) — Gross Profit: 14755000.00
UROY income_statement (annual, 2024-04-30) — Interest Expense: 9000.00
UROY income_statement (annual, 2024-04-30) — Interest Expense Non Operating: 9000.00
UROY income_statement (annual, 2024-04-30) — Interest Income: 692000.00
UROY income_statement (annual, 2024-04-30) — Interest Income Non Operating: 692000.00
UROY cash_flow (annual, 2024-04-30) — Interest Paid Cff: -167000.00
UROY cash_flow (annual, 2024-04-30) — Interest Received Cfi: 693000.00
UROY balance_sheet (annual, 2024-04-30) — Inventory: 187090000.00
UROY balance_sheet (annual, 2024-04-30) — Invested Capital: 275789000.00
UROY cash_flow (annual, 2024-04-30) — Investing Cash Flow: 45235000.00
UROY cash_flow (annual, 2024-04-30) — Issuance Of Capital Stock: 70479000.00
UROY balance_sheet (annual, 2024-04-30) — Long Term Capital Lease Obligation: 156000.00
UROY balance_sheet (annual, 2024-04-30) — Long Term Debt And Capital Lease Obligation: 156000.00
UROY cash_flow (annual, 2024-04-30) — Long Term Debt Payments: -20000.00
UROY cash_flow (annual, 2024-04-30) — Net Common Stock Issuance: 70479000.00
UROY cash_flow (annual, 2024-04-30) — Net Foreign Currency Exchange Gain Loss: 201000.00
UROY income_statement (annual, 2024-04-30) — Net Income: 9780000.00
UROY income_statement (annual, 2024-04-30) — Net Income Common Stockholders: 9780000.00
UROY income_statement (annual, 2024-04-30) — Net Income Continuous Operations: 9780000.00
UROY income_statement (annual, 2024-04-30) — Net Income From Continuing And Discontinued Operation: 9780000.00
UROY income_statement (annual, 2024-04-30) — Net Income From Continuing Operation Net Minority Interest: 9780000.00
UROY cash_flow (annual, 2024-04-30) — Net Income From Continuing Operations: 7757000.00
UROY income_statement (annual, 2024-04-30) — Net Income Including Noncontrolling Interests: 9780000.00
UROY income_statement (annual, 2024-04-30) — Net Interest Income: 683000.00
UROY cash_flow (annual, 2024-04-30) — Net Investment Purchase And Sale: 44617000.00
UROY cash_flow (annual, 2024-04-30) — Net Issuance Payments Of Debt: -9609000.00
UROY cash_flow (annual, 2024-04-30) — Net Long Term Debt Issuance: -20000.00
UROY income_statement (annual, 2024-04-30) — Net Non Operating Interest Income Expense: 683000.00
UROY balance_sheet (annual, 2024-04-30) — Net PPE: 46952000.00
UROY cash_flow (annual, 2024-04-30) — Net PPE Purchase And Sale: -75000.00
UROY cash_flow (annual, 2024-04-30) — Net Short Term Debt Issuance: -9589000.00
UROY balance_sheet (annual, 2024-04-30) — Net Tangible Assets: 275789000.00
UROY income_statement (annual, 2024-04-30) — Normalized EBITDA: 7990000.00
UROY income_statement (annual, 2024-04-30) — Normalized Income: 9950850.00
UROY cash_flow (annual, 2024-04-30) — Operating Cash Flow: -104843000.00
UROY cash_flow (annual, 2024-04-30) — Operating Gains Losses: 201000.00
UROY income_statement (annual, 2024-04-30) — Operating Income: 7077000.00
UROY income_statement (annual, 2024-04-30) — Operating Revenue: 42706000.00
UROY balance_sheet (annual, 2024-04-30) — Ordinary Shares Number: 120554333.00
UROY balance_sheet (annual, 2024-04-30) — Other Equity Adjustments: 8870000.00
UROY income_statement (annual, 2024-04-30) — Other Gand A: 5117000.00
UROY income_statement (annual, 2024-04-30) — Other Income Expense: -3000.00
UROY cash_flow (annual, 2024-04-30) — Other Non Cash Items: -868000.00